sur OXURION (EBR:OXUR)
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
On July 15, 2025, Oxurion NV, a biopharmaceutical company located in Leuven, Belgium, announced it had received a transparency notification, in line with Belgian legislation, from Atlas Special Opportunities II, LLC. The notification indicated that as of July 14, 2025, Atlas held 2,751,917 shares of Oxurion, representing a reduction below the 25% threshold of the company's 12,428,021 outstanding shares. This change is due to the selling of voting securities by Atlas.
The notification aligns with Article 14 of the Law of May 2, 2007, focusing on disclosure of significant holdings. Oxurion continues to align its operations with regulatory requirements while advancing its biotechnological innovations.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de OXURION